Girish R. Mood, MD, Heather L. Gornik, MD, MHS, Vidyasagar Kalahasti, MD, Donald Hammer, MD, W. H. Wilson Tang, MD, FAHA. High Incidence of Venous Thrombosis.

Slides:



Advertisements
Similar presentations
Nursing Care & Interventions for Clients with Vascular Problems
Advertisements

DEEP VEIN THROMBOSIS.
Farmaci usati prima dellintervento Basi farmacologiche del loro uso La prevenzione del tromboembolismo.
Off pump CABG has been performed for the first time 40 years ago. Although conventional CABG is considered both safe and effective, the use of CBP.
Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
VTE Toolkit Chapter Five Venous Disease Coalition
Risk stratification and incidence of acute complications in upper extremity deep vein thrombosis (UEDVT) patients. Dr. Santosh Yatam Ganesh MBBS, MPH.,
Rate of Obstructive Coronary Disease in Elective Diagnostic Cath Manesh R. Patel, MD Assistant Professor of Medicine Director Cath Lab Research – Duke.
Surgical Care Improvement Project - Pharmacy Process Improvement (Software) Mark Wong, Pharm.D., BCPS 1,2,3 ; George Melnik, Pharm.D., BCPS, 1,2 South.
The PERC Rule. The paper Kline et al Journal of Thrombosis and Haemostasis 2008 Prospective Multicenter Evaluation of the Pulmonary Embolism Rule Out.
+ Deep Vein Thrombosis Common, Preventable, and potentially Fatal.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Venous Thromboembolism
Deep Vein Thrombosis (DVT)
RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.
1 MCIC VTE Prophylaxis All Team Call Sean Berenholtz, MD MHS and VTE Subcommittee
VTE Prophylaxis Alert to providers and nursing Go live June 24, 2014.
Preparing for Discharge Pain Management and Anticoagulation Therapy Justina Lehman- Lane, FNP, DNP.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
DVT with ankle fractures: Is thromboprophylaxis warranted? Sunit Patil Jamshid Gandhi Ian Curzon Anthony Hui James Cook University Hospital, Middlesbrough.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
2007 Deep Vein Thrombosis (DVT) Awareness Program
1. 2 Definition Definition Causes Causes Risk Factors Risk Factors Symptoms Symptoms Importance Importance Treatments Treatments Content Introduction.
DR FAROOQ AHMAD RANA ASSISTANT PROFESSOR SURGERY
Few Patients With Functional MR Are Treated Surgically: Duke Database Results Mitchell W. Krucoff MD FACC, FAHA, FSCAI Professor of Medicine /
Supervisor: Vs 余垣斌 Presenter: CR 周益聖. INTRODUCTION.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
Postoperative venous thromboembolic disease prevention in the neurosurgery population Ahmad Khaldi, M.D. 1 Michael Wall, PharmD 2 T.C. Origitano, M.D.,
1 Terri Conner,PhD Nybeck Analytics Partnership for Patients 14 th May 2012 USE OF MEDICARE DIAGNOSIS AND PROCEDURE CODES TO IMPROVE DETECTION OF SURGICAL.
ARIXTRA® (fondaparinux sodium) in the prevention of venous thromboembolism after hip-fracture surgery BI Eriksson, KA Bauer, MR Lassen, and AGG Turpie.
Is an Antithrombotic Therapy necessary after Mitral Valve Repair ? Ph Meurin, JY Tabet, MC Iliou, B Pierre, S Corone et A Bendriss, On behalf of the Working.
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Girish R. Mood, MD, Heather L. Gornik, MD, MHS, Vidyasagar Kalahasti, MD, Donald Hammer, MD, W. H. Wilson Tang, MD, FAHA. High Incidence of Venous Thrombosis.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
LIFEBLOOD THE Thrombosis CHARITY LIFEBLOOD THE Thrombosis CHARITY NICE Clinical Guideline 46.
DVT Prevention and Anticoagulant Management
IVC filters what you need to know Sam Chakraverty Consultant Radiologist Ninewells Hospital Dundee, Scotland.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
DVT & PE: How early can I mobilize a patient ??
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
SANOFI-SYNTHELABOARIXTRA ® 1 ARIXTRA ® (fondaparinux sodium) in the prevention of venous thromboembolism after major knee surgery KA Bauer, BI Eriksson,
PE Clinical Evaluation. Presenting Complaint Most common presenting complaint: dyspnoea Chest pain Syncope Cough Leg pain.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Venous Thrombosis and Pulmonary Embolism 1 (RECORD 1 ) Journal Club General Surgery Rotation.
Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
SANOFI-SYNTHELABOARIXTRA ® 1 ARIXTRA ® (fondaparinux sodium) in the prevention of venous thromboembolism after hip replacement surgery KA Bauer, BI Eriksson,
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
Cardiac Rehabilitation after Mitral Valve Repair Ph Meurin, MC Iliou, A Bendriss, B Pierre, S Corone,P Cristofini et JY Tabet On behalf of the Working.
Oral Rivaroxaban Compared with Subcutaneous Enoxaparin for Extended Thromboprophylaxis After Total Hip Arthroplasty: The RECORD1 Trial Eriksson BI, Borris.
Venous Thromboembolism (VTE) Prophylaxis at Cesarean Section Phillip N. Rauk, MD.
Maile Parker, MSIV University of Washington School of Medicine Sept. 27, 2012 Venous Thromboembolism Prophylaxis in Pediatric Patients With Central Venous.
Fundamental Research in Oncology & Thrombosis FRONTLINE 1 Survey.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Conclusions Results Methods Background Venous thrombo-embolism in patients undergoing neo- adjuvant chemotherapy and surgery for oesophago-gastric cancer.
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy.
Comparison of Patient Satisfaction and Time Spent in Therapeutic Range in Two Different Clinic Models Ashley Pokallus, PharmD PGY1 Pharmacy Resident—Ambulatory.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010.
What Is Deep Vein Thrombosis (DVT)? DVT is a blood clot that forms in a vein deep in the body Most often occurs in the deep veins of the legs, either.
IN THE NAME OF GOD. What are Stem Cells? Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types.
CRT 2012 Venous Disease.
Venous Thromboembolism Prophylaxis (VTE)
George M. Foulard, William I. Douglas MD
Copyright © 2012 American Medical Association. All rights reserved.
Risk of post-operative stroke in patients with known extra-cranial carotid artery disease undergoing Non-Cardiac Surgery Heart and Vascular.
Jeff Macemon Waikato Cardiothoracic Unit
Don't look now! Risk stratify first
Venous Thromboembolism (VTE)
Heparin-induced thrombosis without thrombocytopenia
Presentation transcript:

Girish R. Mood, MD, Heather L. Gornik, MD, MHS, Vidyasagar Kalahasti, MD, Donald Hammer, MD, W. H. Wilson Tang, MD, FAHA. High Incidence of Venous Thrombosis following Cardiac Surgery

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 2 Background: General Surgery15-40% Major gynecologic surgery15-40% Major urologic surgery15-40% Neurosurgery15-40% Hip or Knee surgery40-60% Spinal cord surgery60-80% Critical care patients10-80% Absolute risk of DVT in hospitalized patients Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest Sep;126(3 Suppl):338S-400S

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 3 Deep venous thrombosis after open heart surgery: 10,638 patients ( ) 7,979 (75%) had CABG 2,659 had valve ± CABG 77 (0.7%) had DVT 36 patients had DVT without PE 41 patients had PE 16 patients had DVT being treated with heparin 25 patients without DVT Patients with LE edema, pain, ↑ temp underwent Imaging studies DeLaria GA, Hunter JA. Deep venous thrombosis. Implications after open heart surgery. Chest Feb;99(2):284-8

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 4 Deep venous thrombosis following hospital discharge: 270 patients entering cardiac rehabilitation after CABG 47 (17.4%) patients had DVT 2 (0.7%) patients with DVT had PE Excluded patients with prior DVT, Concomitant non coronary or valve surgery 171 (63%) were on heparin prophylaxis Ambrosetti M, Salerno M, Zambelli M, Mastropasqua F, Tramarin R, Pedretti RF. Deep vein thrombosis among patients entering cardiac rehabilitation after coronary artery bypass surgery. Chest 2004;125:191-6

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 5 Aim of the study: To evaluate incidence of symptomatic venous thrombosis after contemporary open heart surgery To evaluate the relative time course and presenting locations of venous thrombosis

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 6 Inclusion criteria: All patients who underwent cardiac surgery (emergent and non emergent) during the year 01/2004 to 12/2006 Patients evaluated with imaging studies for clinical suspicion of venous thrombosis - Swelling, warmth, redness, pain related to the extremity - Heparin induced thrombocytopenia Exclusion criteria: Patients with known venous thrombosis prior to the surgery

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 7 Methods: Detailed post-operative data prospectively collected via Cleveland Clinic Cardiovascular Information Registry database (CVIR) Vascular study information up to 30 days post-op reviewed Stratified according to location of venous thrombosis; superficial venous thrombosis or deep venous thrombosis

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 8 Definitions: Early venous thrombosis was defined as positive results between 0-15 days from the surgery Late venous thrombosis was defined as positive results between days after the surgery

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 9 Results: 10,588 (01/ /2006) 1,667 (15.7%) Underwent imaging studies 1,272 (12.0%) All positive venous thrombosis 870 (8.2%) DVT positive 152 Excluded for known venous thrombosis prior to surgery

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 10 Site of venous thrombosis: 870 DVT positive 428 (49.2%) Positive LE DVT 442 (50.8%) Positive UE DVT 304 (34.9%) Calf vein DVT 396 (45.5%) IJ vein DVT

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 11 Time to thrombosis (Deep venous thrombosis): Time in Days

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 12 Time to thrombosis (superficial and deep venous thrombosis): Time in days

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 13 Deep venous thrombosis in CABG and valve surgery only: 14.9% 14% 9.7% 16.3%

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 14 Limitation: Single center, registry based study May not include the studies performed outside the central vascular lab Details of venous access site were not available Selection bias of clinically indicated vascular studies

High Incidence of Venous Thrombosis following Cardiac Surgery l November 7, 2007 l 15 Conclusion: Symptomatic venous thrombosis was found in 12% of patients undergoing open heart surgery in the contemporary era Incidence of deep venous thrombosis was 8.2% Over 3/4 th of venous thrombosis were detected within 15 days post-operatively Internal jugular (45.5%) and calf vein thromboses (34.9%) being the most common sites.